Stock Analysis on Net
Stock Analysis on Net

Gilead Sciences Inc. (NASDAQ:GILD)

デュポンの分析: ROE、ROA、純利益率の内訳 
四半期データ

Microsoft Excel

ROE分解では、純利益を株主資本で割ったものを構成比率の積として表します。

ROEを2つのコンポーネントに分解

Gilead Sciences Inc.、 ROE の分解(四半期データ)

Microsoft Excel
ROE = ROA × 財務レバレッジ比率
2025/03/31 31.13% = 10.57% × 2.95
2024/12/31 2.48% = 0.81% × 3.05
2024/09/30 0.69% = 0.23% × 2.95
2024/06/30 5.77% = 1.97% × 2.93
2024/03/31 2.77% = 0.86% × 3.21
2023/12/31 24.81% = 9.12% × 2.72
2023/09/30 26.33% = 9.42% × 2.80
2023/06/30 25.92% = 8.80% × 2.95
2023/03/31 26.59% = 9.02% × 2.95
2022/12/31 21.62% = 7.27% × 2.97
2022/09/30 15.82% = 5.33% × 2.97
2022/06/30 20.44% = 6.58% × 3.11
2022/03/31 22.66% = 7.16% × 3.17
2021/12/31 29.55% = 9.16% × 3.23
2021/09/30 34.44% = 11.02% × 3.13
2021/06/30 26.20% = 7.59% × 3.45
2021/03/31 1.59% = 0.45% × 3.56
2020/12/31 0.68% = 0.18% × 3.76
2020/09/30 — = — × 3.49
2020/06/30 — = — × 3.10
2020/03/31 — = — × 2.71

レポートに基づく: 10-Q (報告日: 2025-03-31), 10-K (報告日: 2024-12-31), 10-Q (報告日: 2024-09-30), 10-Q (報告日: 2024-06-30), 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31).

2025年第1 四半期の株主資本利益率(ROE)が上昇した主な理由は、総資産利益率(ROA)で測定される収益性の向上です。

ROEを3つの要素に分解

Gilead Sciences Inc.、 ROE の分解(四半期データ)

Microsoft Excel
ROE = 純利益率 × 資産回転率 × 財務レバレッジ比率
2025/03/31 31.13% = 20.87% × 0.51 × 2.95
2024/12/31 2.48% = 1.68% × 0.48 × 3.05
2024/09/30 0.69% = 0.45% × 0.52 × 2.95
2024/06/30 5.77% = 3.82% × 0.52 × 2.93
2024/03/31 2.77% = 1.78% × 0.48 × 3.21
2023/12/31 24.81% = 21.03% × 0.43 × 2.72
2023/09/30 26.33% = 21.60% × 0.44 × 2.80
2023/06/30 25.92% = 20.18% × 0.44 × 2.95
2023/03/31 26.59% = 20.87% × 0.43 × 2.95
2022/12/31 21.62% = 17.02% × 0.43 × 2.97
2022/09/30 15.82% = 12.44% × 0.43 × 2.97
2022/06/30 20.44% = 15.22% × 0.43 × 3.11
2022/03/31 22.66% = 16.60% × 0.43 × 3.17
2021/12/31 29.55% = 23.05% × 0.40 × 3.23
2021/09/30 34.44% = 27.21% × 0.41 × 3.13
2021/06/30 26.20% = 19.62% × 0.39 × 3.45
2021/03/31 1.59% = 1.19% × 0.37 × 3.56
2020/12/31 0.68% = 0.51% × 0.36 × 3.76
2020/09/30 — = — × — × 3.49
2020/06/30 — = — × — × 3.10
2020/03/31 — = — × — × 2.71

レポートに基づく: 10-Q (報告日: 2025-03-31), 10-K (報告日: 2024-12-31), 10-Q (報告日: 2024-09-30), 10-Q (報告日: 2024-06-30), 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31).

2025年第1 四半期の株主資本利益率(ROE)が上昇した主な理由は、純利益率で測定される収益性の向上です。

ROEを5つの要素に分解

Gilead Sciences Inc.、 ROE の分解(四半期データ)

Microsoft Excel
ROE = 税負担 × 利息負担 × EBITマージン × 資産回転率 × 財務レバレッジ比率
2025/03/31 31.13% = 0.87 × 0.87 × 27.32% × 0.51 × 2.95
2024/12/31 2.48% = 0.70 × 0.41 × 5.83% × 0.48 × 3.05
2024/09/30 0.69% = 0.67 × 0.16 × 4.16% × 0.52 × 2.95
2024/06/30 5.77% = 0.68 × 0.62 × 9.17% × 0.52 × 2.93
2024/03/31 2.77% = 0.44 × 0.53 × 7.58% × 0.48 × 3.21
2023/12/31 24.81% = 0.82 × 0.88 × 29.16% × 0.43 × 2.72
2023/09/30 26.33% = 0.81 × 0.89 × 30.16% × 0.44 × 2.80
2023/06/30 25.92% = 0.74 × 0.89 × 30.56% × 0.44 × 2.95
2023/03/31 26.59% = 0.76 × 0.89 × 30.79% × 0.43 × 2.95
2022/12/31 21.62% = 0.79 × 0.86 × 25.11% × 0.43 × 2.97
2022/09/30 15.82% = 0.73 × 0.83 × 20.57% × 0.43 × 2.97
2022/06/30 20.44% = 0.74 × 0.85 × 24.07% × 0.43 × 3.11
2022/03/31 22.66% = 0.77 × 0.86 × 25.25% × 0.43 × 3.17
2021/12/31 29.55% = 0.75 × 0.89 × 34.45% × 0.40 × 3.23
2021/09/30 34.44% = 0.79 × 0.90 × 38.22% × 0.41 × 3.13
2021/06/30 26.20% = 0.77 × 0.87 × 29.50% × 0.39 × 3.45
2021/03/31 1.59% = 0.15 × 0.66 × 11.73% × 0.37 × 3.56
2020/12/31 0.68% = 0.07 × 0.63 × 11.03% × 0.36 × 3.76
2020/09/30 — = — × — × — × — × 3.49
2020/06/30 — = — × — × — × — × 3.10
2020/03/31 — = — × — × — × — × 2.71

レポートに基づく: 10-Q (報告日: 2025-03-31), 10-K (報告日: 2024-12-31), 10-Q (報告日: 2024-09-30), 10-Q (報告日: 2024-06-30), 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31).

2025年第1 四半期の株主資本利益率(ROE)が上昇した主な理由は、EBITマージン率で測定される営業利益率の増加です。

ROAを2つのコンポーネントに分解

Gilead Sciences Inc.、 ROA の分解(四半期データ)

Microsoft Excel
ROA = 純利益率 × 資産回転率
2025/03/31 10.57% = 20.87% × 0.51
2024/12/31 0.81% = 1.68% × 0.48
2024/09/30 0.23% = 0.45% × 0.52
2024/06/30 1.97% = 3.82% × 0.52
2024/03/31 0.86% = 1.78% × 0.48
2023/12/31 9.12% = 21.03% × 0.43
2023/09/30 9.42% = 21.60% × 0.44
2023/06/30 8.80% = 20.18% × 0.44
2023/03/31 9.02% = 20.87% × 0.43
2022/12/31 7.27% = 17.02% × 0.43
2022/09/30 5.33% = 12.44% × 0.43
2022/06/30 6.58% = 15.22% × 0.43
2022/03/31 7.16% = 16.60% × 0.43
2021/12/31 9.16% = 23.05% × 0.40
2021/09/30 11.02% = 27.21% × 0.41
2021/06/30 7.59% = 19.62% × 0.39
2021/03/31 0.45% = 1.19% × 0.37
2020/12/31 0.18% = 0.51% × 0.36
2020/09/30 — = — × —
2020/06/30 — = — × —
2020/03/31 — = — × —

レポートに基づく: 10-Q (報告日: 2025-03-31), 10-K (報告日: 2024-12-31), 10-Q (報告日: 2024-09-30), 10-Q (報告日: 2024-06-30), 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31).

2025年第1 四半期の総資産利益率(ROA)が上昇した主な理由は、純利益率で測定した収益性の向上です。

ROAを4つの要素に分解

Gilead Sciences Inc.、 ROA の分解(四半期データ)

Microsoft Excel
ROA = 税負担 × 利息負担 × EBITマージン × 資産回転率
2025/03/31 10.57% = 0.87 × 0.87 × 27.32% × 0.51
2024/12/31 0.81% = 0.70 × 0.41 × 5.83% × 0.48
2024/09/30 0.23% = 0.67 × 0.16 × 4.16% × 0.52
2024/06/30 1.97% = 0.68 × 0.62 × 9.17% × 0.52
2024/03/31 0.86% = 0.44 × 0.53 × 7.58% × 0.48
2023/12/31 9.12% = 0.82 × 0.88 × 29.16% × 0.43
2023/09/30 9.42% = 0.81 × 0.89 × 30.16% × 0.44
2023/06/30 8.80% = 0.74 × 0.89 × 30.56% × 0.44
2023/03/31 9.02% = 0.76 × 0.89 × 30.79% × 0.43
2022/12/31 7.27% = 0.79 × 0.86 × 25.11% × 0.43
2022/09/30 5.33% = 0.73 × 0.83 × 20.57% × 0.43
2022/06/30 6.58% = 0.74 × 0.85 × 24.07% × 0.43
2022/03/31 7.16% = 0.77 × 0.86 × 25.25% × 0.43
2021/12/31 9.16% = 0.75 × 0.89 × 34.45% × 0.40
2021/09/30 11.02% = 0.79 × 0.90 × 38.22% × 0.41
2021/06/30 7.59% = 0.77 × 0.87 × 29.50% × 0.39
2021/03/31 0.45% = 0.15 × 0.66 × 11.73% × 0.37
2020/12/31 0.18% = 0.07 × 0.63 × 11.03% × 0.36
2020/09/30 — = — × — × — × —
2020/06/30 — = — × — × — × —
2020/03/31 — = — × — × — × —

レポートに基づく: 10-Q (報告日: 2025-03-31), 10-K (報告日: 2024-12-31), 10-Q (報告日: 2024-09-30), 10-Q (報告日: 2024-06-30), 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31).

2025年第1 四半期の総資産利益率(ROA)が上昇した主な理由は、EBITマージン率で測定した営業利益率の増加です。

当期純利益率の分解

Gilead Sciences Inc.、純利益率の分解(四半期データ)

Microsoft Excel
純利益率 = 税負担 × 利息負担 × EBITマージン
2025/03/31 20.87% = 0.87 × 0.87 × 27.32%
2024/12/31 1.68% = 0.70 × 0.41 × 5.83%
2024/09/30 0.45% = 0.67 × 0.16 × 4.16%
2024/06/30 3.82% = 0.68 × 0.62 × 9.17%
2024/03/31 1.78% = 0.44 × 0.53 × 7.58%
2023/12/31 21.03% = 0.82 × 0.88 × 29.16%
2023/09/30 21.60% = 0.81 × 0.89 × 30.16%
2023/06/30 20.18% = 0.74 × 0.89 × 30.56%
2023/03/31 20.87% = 0.76 × 0.89 × 30.79%
2022/12/31 17.02% = 0.79 × 0.86 × 25.11%
2022/09/30 12.44% = 0.73 × 0.83 × 20.57%
2022/06/30 15.22% = 0.74 × 0.85 × 24.07%
2022/03/31 16.60% = 0.77 × 0.86 × 25.25%
2021/12/31 23.05% = 0.75 × 0.89 × 34.45%
2021/09/30 27.21% = 0.79 × 0.90 × 38.22%
2021/06/30 19.62% = 0.77 × 0.87 × 29.50%
2021/03/31 1.19% = 0.15 × 0.66 × 11.73%
2020/12/31 0.51% = 0.07 × 0.63 × 11.03%
2020/09/30 — = — × — × —
2020/06/30 — = — × — × —
2020/03/31 — = — × — × —

レポートに基づく: 10-Q (報告日: 2025-03-31), 10-K (報告日: 2024-12-31), 10-Q (報告日: 2024-09-30), 10-Q (報告日: 2024-06-30), 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31).

2025年第1 四半期の純利益率の上昇の主な理由は、EBITマージン率で測定される営業利益率の増加です。